Litigation Details for Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc. (Fed. Cir. 2022)
✉ Email this page to a colleague
Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc. (Fed. Cir. 2022)
Docket | ⤷ Try a Trial | Date Filed | 2022-11-21 |
Court | Court of Appeals for the Federal Circuit | Date Terminated | |
Cause | Assigned To | ||
Jury Demand | Referred To | ||
Patents | 10,278,935; 10,383,840; 10,568,861; 7,022,713; 7,511,131; 8,293,727; 8,293,728; 8,298,554; 8,314,086; 8,318,715; 8,357,677; 8,367,652; 8,377,920; 8,410,086; 8,431,560; 8,440,650; 8,455,472; 8,518,929; 8,524,698; 8,546,372; 8,551,521; 8,563,608; 8,617,593; 8,617,594; 8,623,406; 8,642,077; 8,669,245; 8,680,144; 8,691,871; 8,703,185; 8,709,475; 9,603,826; 9,610,272; 9,623,001; 9,693,984; 9,693,985; 9,693,986; 9,700,537; 9,918,954 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc.
Details for Amarin Pharma, Inc. v. Hikma Pharmaceuticals USA Inc. (Fed. Cir. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2023-03-21 | 15 | 005,852, filed on Jun. 12, 2018, now Pat. No. 10,278,935, which is a continuation of application …present filed Jun. 12, 2018 (now U.S. Pat. No. 10,278,935), which …asserted patents the ’537 and ’861 patents USPTO United States Patent and Trademark…relationship between the non-patented use and patented use is reversed: the non- patented use here (i.e., the …the broader, off-patent use induced the specific, patented use because the off-patented treatment of severe | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |